S&P said cost sharing reductions, short-term assistance funds and stabilization funds for the states provided under the BCRA would have a positive effect on the individual insurance market from 2018 to 2021.
However, S&P said the proposed bill fails to create a long-term sustainable market, as there would be a “sharp drop in access” to health insurance after 2021.
For the individual market, the decline in access would be caused by a reduction in federal funding for advanced premium tax credits through the use of a “lower actuarial value for the benchmark plan” and elimination of the ACA’s individual mandate, according to S&P.
More articles on healthcare finance:
Surgical hospital owner, operator files for bankruptcy
Centegra to end acute inpatient care at Illinois hospital as losses mount
Stocks slide after Senate delays vote on healthcare bill
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
